These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4276528)

  • 1. Proceedings: On antifibrillatory properties of cardiac glycosides.
    Brassel G; Lange-Asschenfeldt H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R12. PubMed ID: 4276528
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute electrophysiological effects of cardiac glycosides on sinus node function and ventricular repolarization under clinical conditions].
    Lauten A; Abmann I; Knappe J
    Cor Vasa; 1987; 29(6):436-43. PubMed ID: 3436148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations.
    Haustein KO; Graumann G; Stephan B
    Acta Biol Med Ger; 1975; 34(6):1065-73. PubMed ID: 1199622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrillatory effect of tetrahydroberberine.
    Sun AY; Li DX
    Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):301-5. PubMed ID: 8249620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic distinctions between ouabain, digoxin and digitoxin.
    Runge TM; Stephens JC; Holden P; Havemann DF; Kilgore WM; Dale EM; Dalton RE
    Arch Int Pharmacodyn Ther; 1975 Mar; 214(1):31-45. PubMed ID: 1156023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possibilities and problems or long-term therapy using cardiac glycosides].
    Gillmann H
    Z Gesamte Inn Med; 1973 Feb; 28(3):41-5 passim. PubMed ID: 4633782
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of cardiac glycosides on the diastole of the heart].
    Storz H
    Dtsch Med Wochenschr; 1970 Jan; 95(5):224-7. PubMed ID: 5410907
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of proscillaridin A in the therapy of cardiac insufficiency in the aged].
    Castrucci D; Morini PL
    Minerva Med; 1967 Nov; 58(91):3917-21. PubMed ID: 6081708
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the sugar component in cardiac glycosides on their action in patients with auricular fibrillation and congestive failure.
    Gold H; Kwit NT; Shane SJ; Dayrit C
    J Clin Pharmacol J New Drugs; 1969; 9(3):148-54. PubMed ID: 5255179
    [No Abstract]   [Full Text] [Related]  

  • 11. [Functional state of the sinus and atrioventricular nodes in fibrillation arrhythmia in cardiac ischemia patients].
    Ostapiuk FE
    Kardiologiia; 1973 May; 13(5):38-42. PubMed ID: 4720566
    [No Abstract]   [Full Text] [Related]  

  • 12. [Practical use of cardiac glycosides].
    Ignat'ev MV
    Voen Med Zh; 1976 Sep; (9):78-80. PubMed ID: 1034366
    [No Abstract]   [Full Text] [Related]  

  • 13. Current status of cardiac glycoside drug interactions.
    Hooymans PM; Merkus FW
    Clin Pharm; 1985; 4(4):404-13. PubMed ID: 2412751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological and other effects on cardiac function of KO 1173.
    Singh BN; Williams EM
    Br Heart J; 1973 May; 35(5):558. PubMed ID: 4716038
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiac glycosides: indications, selection and dosage].
    Kuhlmann J
    Med Klin; 1982 Jan; 77(3):18-22. PubMed ID: 7057727
    [No Abstract]   [Full Text] [Related]  

  • 16. Difference in degree of A-V block and QS2 abbreviation of ouabain digoxin and digitoxin in cats.
    Runge TM; Shapowal BL
    Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):194-204. PubMed ID: 3718085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early postmyocardial infarction ventricular arrhythmias.
    Brugada P; Andries EW
    Cardiovasc Clin; 1992; 22(1):165-80. PubMed ID: 1728424
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of chronic cardiac insufficiency with cardiac glycosides].
    Bonelli J
    Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative characteristics of the experimental antifibrillatory action of anti-arrhythmia preparations].
    Storozhuk BG; Stoliarchuk AA
    Farmakol Toksikol; 1980; 43(5):579-81. PubMed ID: 7449988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.